NEW YORK, May 30 -- Capital Genomix and the Blanchette Rockefeller Neurosciences Institute plan to establish a microarray core facility, Capital said yesterday.
The facility, to be housed at JohnsHopkinsUniversity's Shady Grove campus in Gaithersburg, Md., will be headed by microarray researcher Pachiappan Manickam.
Capital, based in Chantilly, Va., holds a microarray service license from Affymetrix. The company expects the collaboration with BRNI will expand to include its own gene expression and antibody technologies, called GeneSystem320 and ImmunoMouse, respectively.
BRNI is a non-profit institute focusing on translational research in the area of Alzheimer's disease.